Neurovascular Neuropsychology

This book covers the explosion of new information about the relationship between the brain and its blood supply since the first edition was published in 2009.  With new knowledge and its impact on clinical care, neurovascular neuropsychology has become a recognized sub-specialty that has been integrated into health care systems in the US and abroad.  The second edition brings to this larger audience the latest word on these matters, with new emphasis on women’s issues, relevance to the pediatric population, insights from modern imaging, and advances in medical and surgical treatments such as heart transplantation, cardiovascular transarterial therapies, and noninvasive brain stimulation in connection with neurocognitive outcomes. 

• neurovascular geography and imaging
• ischemia and cerebral hemorrhage
• cerebral aneurysms
• arteriovenous malformations
• vascular cognitive impairment
• vascular dementia
• CADASIL and MELAS
• cognition and cardiac surgery
• cognition and cardiovascular transarterial therapies
• lung transplantation and cognition
• carotid artery disease and cognition
• congestive heart failure and cognition
• pediatric vascular conditions and cognition
• pharmacological intervention for stroke recovery
• noninvasive brain stimulation for diagnosis and treatment
• rehabilitation from brain injury
• neuropsychology and neurosurgery
• pediatric neurovascular neuropsychology
• neurovascular neuropsychology and women
• rehabilitation psychology

• UAB Evelyn F. McKnight Brain Institute, Department of Neurology, University of Alabama at Birmingham, Birmingham, USA

  Ronald M. Lazar

• Department of Neurology, Neurological Institute, Columbia University Irving Medical Center, New York, USA

  MaryKay A. Pavol

• Division of Geriatric Behavioral Health, Department of Psychiatry & Behavioral Sciences, Duke University Medical Center, Durham, USA

  Jeffrey N. Browndyke

Ronald M. Lazar, PhD, FAHA, FAAN,  is Professor of Neurology and Neurobiology  in the Department of Neurology at the University of Alabama at Birmingham. He holds the Evelyn F. McKnight Endowed Chair and is Director of the UAB McKnight Brain Institute, and Director of the Division of Neuropsychology in the School of Medicine at UAB. He received his undergraduate degree at New York University and his PhD at Northeastern University. Funded by NIH, Dr. Lazar has broad interests in aging and vascular disease, with emphases on reversible causes of cognitive decline, risk-factor modification to promote cognitive resiliency, and recovery after stroke.

Marykathryn Pavol, PhD is a clinical neuropsychologist at the Neurological Institute at the Columbia University Medical Center, with 21 years of experience in neuropsychology and clinical psychology. She received her PhD degree at the University of Texas Health Sciences Center, Houston. Her clinical research is focused on disorders of blood flow to the brain and the relationships between cognitive function and self-care capabilities.

Jeffrey Browndyke, PhD is a faculty member of department of psychiatry and behavioral sciences at Duke University, and he holds affiliate faculty appointments with the Duke Brain Imaging and Analysis Center, Duke Institute for Brain Science, and Center for Cognitive Neuroscience. He has dual appointment to the Duke University Medical Center and the Durham VA Medical Center. Dr. Browndyke's clinical expertise is focused on adult and geriatric populations with an emphasis in the assessment, diagnosis, and treatment of dementia and related disorders, and forensic/medicolegal evaluation of adults and veteran patient populations. 

Policies and ethics